One Plus One Wealth Management LLC Trims Position in Chemed Co. (NYSE:CHE)

One Plus One Wealth Management LLC cut its holdings in shares of Chemed Co. (NYSE:CHE) by 26.5% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 831 shares of the company’s stock after selling 300 shares during the period. One Plus One Wealth Management LLC’s holdings in Chemed were worth $511,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. UMB Bank n.a. grew its stake in Chemed by 219.2% in the first quarter. UMB Bank n.a. now owns 166 shares of the company’s stock worth $102,000 after purchasing an additional 114 shares during the period. KFG Wealth Management LLC grew its stake in Chemed by 4.6% in the first quarter. KFG Wealth Management LLC now owns 525 shares of the company’s stock worth $323,000 after purchasing an additional 23 shares during the period. Impact Capital Partners LLC grew its stake in Chemed by 2.7% in the first quarter. Impact Capital Partners LLC now owns 763 shares of the company’s stock worth $469,000 after purchasing an additional 20 shares during the period. Signal Advisors Wealth LLC grew its stake in Chemed by 28.4% in the first quarter. Signal Advisors Wealth LLC now owns 6,412 shares of the company’s stock worth $3,945,000 after purchasing an additional 1,417 shares during the period. Finally, Vest Financial LLC purchased a new stake in Chemed in the first quarter worth $2,669,000. 95.85% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. Wall Street Zen raised Chemed from a “hold” rating to a “buy” rating in a research note on Friday, March 7th. Royal Bank of Canada increased their target price on Chemed from $667.00 to $674.00 and gave the stock an “outperform” rating in a research note on Monday, April 28th.

Chemed Trading Up 0.2%

NYSE CHE opened at $561.84 on Friday. Chemed Co. has a 12 month low of $512.12 and a 12 month high of $623.61. The stock has a market cap of $8.22 billion, a P/E ratio of 28.39, a P/E/G ratio of 2.15 and a beta of 0.54. The stock’s fifty day moving average price is $575.83 and its 200-day moving average price is $566.16.

Chemed (NYSE:CHE) last released its earnings results on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, topping analysts’ consensus estimates of $5.59 by $0.04. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm had revenue of $646.94 million for the quarter, compared to analysts’ expectations of $641.78 million. During the same period in the prior year, the firm posted $5.20 earnings per share. The company’s quarterly revenue was up 9.8% on a year-over-year basis. As a group, analysts forecast that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 17th. Stockholders of record on Thursday, May 29th will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.36%. The ex-dividend date is Thursday, May 29th. Chemed’s payout ratio is currently 9.74%.

Insider Activity

In other news, CEO Kevin J. Mcnamara sold 1,000 shares of the company’s stock in a transaction on Monday, March 31st. The stock was sold at an average price of $615.33, for a total transaction of $615,330.00. Following the transaction, the chief executive officer now directly owns 101,679 shares of the company’s stock, valued at $62,566,139.07. This represents a 0.97% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Spencer S. Lee sold 1,500 shares of the company’s stock in a transaction on Friday, May 16th. The shares were sold at an average price of $577.99, for a total value of $866,985.00. Following the transaction, the executive vice president now directly owns 14,627 shares in the company, valued at approximately $8,454,259.73. The trade was a 9.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 5,500 shares of company stock valued at $3,213,780 over the last ninety days. 3.29% of the stock is currently owned by corporate insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.